{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/recent","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-06T13:32:22.878Z"},"count":50,"filters":{"office":"Center for Drug Evaluation and Research | CDER"},"items":[{"id":"1ccdeadb6bcc88e4","posted_date":"2024-07-09","letter_issue_date":"2024-06-18","company_name":"Laboratorio Magnachem International","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/1ccdeadb6bcc88e4"},{"id":"9d03473dce6cb142","posted_date":"2024-07-09","letter_issue_date":"2024-06-26","company_name":"reBom Co., Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/9d03473dce6cb142"},{"id":"ca2f02965dc37ebe","posted_date":"2024-07-02","letter_issue_date":"2024-06-24","company_name":"Ozempen.com","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet","canonical_url":"https://api.morvs.ai/fda-warning/ca2f02965dc37ebe"},{"id":"040055c33e96f303","posted_date":"2024-05-28","letter_issue_date":"2024-05-13","company_name":"Aruba Aloe Balm N.V.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/040055c33e96f303"},{"id":"3ae794aad73d8597","posted_date":"2024-05-28","letter_issue_date":"2024-04-30","company_name":"Ward Smelling Salts","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/3ae794aad73d8597"},{"id":"f78bbc380a8e17c4","posted_date":"2024-05-14","letter_issue_date":"2024-05-03","company_name":"Natuzen Co., Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/f78bbc380a8e17c4"},{"id":"f1f156b37d9cb7db","posted_date":"2024-05-14","letter_issue_date":"2024-04-30","company_name":"Grupo Quimico SRL","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/f1f156b37d9cb7db"},{"id":"2a6499248140ca93","posted_date":"2024-05-07","letter_issue_date":"2024-05-02","company_name":"Kevin R. Bender, M.D./DBC Research Corporation","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Clinical Investigator","canonical_url":"https://api.morvs.ai/fda-warning/2a6499248140ca93"},{"id":"1113c200e7600660","posted_date":"2024-05-07","letter_issue_date":"2024-04-30","company_name":"Global Cosmetics Company Limited","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/1113c200e7600660"},{"id":"476c53e7426af7e7","posted_date":"2024-04-30","letter_issue_date":"2024-04-24","company_name":"www.dashpct.com","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet","canonical_url":"https://api.morvs.ai/fda-warning/476c53e7426af7e7"},{"id":"fde3de8a882ede34","posted_date":"2024-04-23","letter_issue_date":"2024-04-18","company_name":"Dr Sankunni’s Ayurvedic Research Foundation Private Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Failure to Register and List","canonical_url":"https://api.morvs.ai/fda-warning/fde3de8a882ede34"},{"id":"c0fcba6235a8fa89","posted_date":"2024-04-23","letter_issue_date":"2024-04-18","company_name":"Zen Enterprises LLC","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Failure to Register and List","canonical_url":"https://api.morvs.ai/fda-warning/c0fcba6235a8fa89"},{"id":"5e4acbf0df851867","posted_date":"2024-04-16","letter_issue_date":"2024-04-11","company_name":"C&T Dream Co., Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/5e4acbf0df851867"},{"id":"002ffe728e8dabb6","posted_date":"2024-04-16","letter_issue_date":"2024-04-08","company_name":"Natco Pharma Limited","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/002ffe728e8dabb6"},{"id":"999a40276ae20e97","posted_date":"2024-04-09","letter_issue_date":"2024-04-03","company_name":"FirstCham Co., Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/999a40276ae20e97"},{"id":"b7f20c8edfe86a87","posted_date":"2024-04-09","letter_issue_date":"2024-04-03","company_name":"Jiangsu Meifan Biotechnology Co. Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/b7f20c8edfe86a87"},{"id":"c6cf7cb6e379ffa2","posted_date":"2024-04-09","letter_issue_date":"2024-03-28","company_name":"Kilitch Healthcare India Limited","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceutical/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/c6cf7cb6e379ffa2"},{"id":"81fe8874f6bbc49a","posted_date":"2024-04-09","letter_issue_date":"2024-03-22","company_name":"Antaria Pty. Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Active Pharmaceutical Ingredient (API)/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/81fe8874f6bbc49a"},{"id":"9074bad829f46c5a","posted_date":"2024-04-02","letter_issue_date":"2024-03-21","company_name":"Betone S.A. de C.V.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/9074bad829f46c5a"},{"id":"93cce9d111066ca3","posted_date":"2024-04-02","letter_issue_date":"2024-03-27","company_name":"Bodywell Natural Skin Care Inc.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug","canonical_url":"https://api.morvs.ai/fda-warning/93cce9d111066ca3"},{"id":"36bb7c9e5533ac7f","posted_date":"2024-03-26","letter_issue_date":"2024-03-25","company_name":"Indelicare DBA INKEEZE","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/36bb7c9e5533ac7f"},{"id":"c9bdabbf349768ff","posted_date":"2024-03-26","letter_issue_date":"2024-03-25","company_name":"TKTX Company","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/c9bdabbf349768ff"},{"id":"62cdb8b3364b6809","posted_date":"2024-03-26","letter_issue_date":"2024-03-25","company_name":"SeeNext Venture, Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/62cdb8b3364b6809"},{"id":"0e1956c49ca45cb0","posted_date":"2024-03-26","letter_issue_date":"2024-03-25","company_name":"Dermal Source, Inc.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/0e1956c49ca45cb0"},{"id":"61c72c5e34c2b1a1","posted_date":"2024-03-26","letter_issue_date":"2024-03-25","company_name":"Tattoo Numbing Cream Co.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/61c72c5e34c2b1a1"},{"id":"badffd557499affd","posted_date":"2024-03-26","letter_issue_date":"2024-03-25","company_name":"Sky Bank Media, LLC dba Painless Tattoo Cream Co.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/badffd557499affd"},{"id":"28484184e70a5286","posted_date":"2024-03-26","letter_issue_date":"2024-03-21","company_name":"New York State Psychiatric Institute IRB","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Institutional Review Board (IRB)","canonical_url":"https://api.morvs.ai/fda-warning/28484184e70a5286"},{"id":"087c042183fc6d1b","posted_date":"2024-03-26","letter_issue_date":"2024-03-18","company_name":"Deqing Jiarou Daily Chemical Co., Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/087c042183fc6d1b"},{"id":"5136307b2524c060","posted_date":"2024-03-26","letter_issue_date":"2024-03-19","company_name":"Ammonia Sport Inc.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/5136307b2524c060"},{"id":"dff198dec33562b1","posted_date":"2024-03-26","letter_issue_date":"2024-03-21","company_name":"Bret R. Rutherford, M.D.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Clinical Investigator (Sponsor)","canonical_url":"https://api.morvs.ai/fda-warning/dff198dec33562b1"},{"id":"3b528bc13fa09b96","posted_date":"2024-03-19","letter_issue_date":"2024-03-13","company_name":"Skull Smash LLC","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/3b528bc13fa09b96"},{"id":"7ccef44977993e0f","posted_date":"2024-03-12","letter_issue_date":"2024-03-08","company_name":"Spirochaete Research Labs, LLC aka Scitus Laboratory Products","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Unapproved New Drugs/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/7ccef44977993e0f"},{"id":"1fccd53623f9a748","posted_date":"2024-03-05","letter_issue_date":"2024-02-09","company_name":"ivsupplyclinic.com","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet","canonical_url":"https://api.morvs.ai/fda-warning/1fccd53623f9a748"},{"id":"aa8f50c855e4b0d9","posted_date":"2024-03-05","letter_issue_date":"2024-02-28","company_name":"Native Salts LLC","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/aa8f50c855e4b0d9"},{"id":"9ef41dd9fb979da8","posted_date":"2024-03-05","letter_issue_date":"2024-02-27","company_name":"Thai Nakorn Patana Co., Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/9ef41dd9fb979da8"},{"id":"d01286aea9676526","posted_date":"2024-03-05","letter_issue_date":"2024-02-22","company_name":"Innovative Formulations, LLC dba Insane Labz","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/d01286aea9676526"},{"id":"59c6ff0f1abc55b3","posted_date":"2024-02-27","letter_issue_date":"2024-02-15","company_name":"LightEyez Limited","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug","canonical_url":"https://api.morvs.ai/fda-warning/59c6ff0f1abc55b3"},{"id":"942407fe0a6f398b","posted_date":"2024-02-27","letter_issue_date":"2024-02-14","company_name":"Amman Pharmaceutical Industries","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/942407fe0a6f398b"},{"id":"d01e628c4c29728c","posted_date":"2024-02-20","letter_issue_date":"2024-02-13","company_name":"Salvacion USA Inc.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Unapproved New Drugs/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/d01e628c4c29728c"},{"id":"cda78bb38b7b792b","posted_date":"2024-02-20","letter_issue_date":"2024-02-05","company_name":"Sichuan Deebio Pharmaceutical Co. Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Active Pharmaceutical Ingredient (API)/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/cda78bb38b7b792b"},{"id":"e972c391196673e1","posted_date":"2024-02-13","letter_issue_date":"2024-02-07","company_name":"Synthetix Inc. DBA Helix Chemical Supply","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Unapproved New Drugs/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/e972c391196673e1"},{"id":"5e114208c9020b5e","posted_date":"2024-02-13","letter_issue_date":"2024-02-06","company_name":"Global Life Technologies Corp.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Unapproved New Drugs/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/5e114208c9020b5e"},{"id":"cff76e6c364b466f","posted_date":"2024-02-13","letter_issue_date":"2024-02-07","company_name":"US Chem Labs","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/cff76e6c364b466f"},{"id":"3e29880acaaf1399","posted_date":"2024-02-13","letter_issue_date":"2024-02-05","company_name":"Ningbo Poplar Daily-Use","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/3e29880acaaf1399"},{"id":"9697f7fd1958f134","posted_date":"2024-02-13","letter_issue_date":"2024-02-01","company_name":"Madhu Instruments Private Limited","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/9697f7fd1958f134"},{"id":"6e5a92072eae36df","posted_date":"2024-02-06","letter_issue_date":"2024-01-31","company_name":"Les Importations Herbasanté Inc.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/6e5a92072eae36df"},{"id":"81722e6f279c4744","posted_date":"2024-02-06","letter_issue_date":"2024-02-02","company_name":"Ehy Holdings, LLC","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Failure to Register and List","canonical_url":"https://api.morvs.ai/fda-warning/81722e6f279c4744"},{"id":"7c935735a32ca747","posted_date":"2024-02-06","letter_issue_date":"2023-11-17","company_name":"Nantong Furuida Packaging Products Co., Ltd.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/7c935735a32ca747"},{"id":"9744395deaf499e1","posted_date":"2024-01-30","letter_issue_date":"2024-01-26","company_name":"S & J International Enterprises Public Company Limited","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/9744395deaf499e1"},{"id":"2199785fc16ebccf","posted_date":"2024-01-30","letter_issue_date":"2024-01-24","company_name":"Sambrosa Care Inc.","issuing_office":"Center for Drug Evaluation and Research | CDER","subject":"Finished Pharmaceuticals/Unapproved New Drug/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/2199785fc16ebccf"}]}